Apple forecast falls short despite iPhone X optimism

Apple Inc. is reportedly launching three new phones that embrace the iPhone X design and will include a wider range of prices, features, and sizes to choose from.

Michael Wolf, chief executive officer and co-founder at Activate, discusses investor and consumer expectations for the newest iPhones from Apple.

Nigeria names Power, Works, Housing Minister, Fashola, Chairman, Health Research Foundation.

John Sfakianakis, director of economic research at the Gulf Research Center, discusses oil supply, demand and prices.

Bob O'Donnell, president at TECHnalysis Research, talks about Netflix Inc.'s results and outlook. Netflix delivered a disappointing forecast for the current quarter, with growth in the U.S. slowing to a near-trickle.

Marci Ryvicker, Wolfe Research managing director, discusses Disney second-quarter earnings and her outlook for the company.

A panel session at the ongoing 59th Annual General Conference of the Nigerian Bar Association focused on space law, exploration and research in Nigeria and the benefit it presents to the country. To discuss his takeaways from the panel session Bart Nnaji, Chairman and CEO of Geometric Power and former Minister of Power in Nigeria joins CNBC Africa’s Christy Cole for more.

Life as a prostitute: Author Emma Becker on working in a brothel to research novel

She's one of the most respected scientists living and working in Africa today. Dr Tebello Nyokong has been awarded South Africa's highest honour, and has received accolades from the African Union and UNESCO for her research into photodynamic therapy and how it can be used to kill cancerous cells without harming any healthy ones. She spoke to us from Johannesburg for Perspective.

Pharmaceuticals are often developed over a long period of time, and can sometimes deliver unexpected effects — as with aspirin and Viagra. Researchers have now used a drug database to discover new anti-cancer substances.

A new HIV treatment, injected every eight weeks, is supposed to reduce stigma and discrimination in Uganda. The drug could be a breakthrough for all those infected — if African leaders are ready to invest.

Genomics research company 54Gene's COVID-19 testing support fund was launched today to increase Nigeria's daily testing capacity. The firm opened the fund with a donation of $150 thousand and has since received an additional $350 thousand from Union Bank. CEO of 54 Gene Abasi Ene-Obong joins CNBC Africa for more.